Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.11

0.11 (0.14%)

07:08
10/05/16
10/05
07:08
10/05/16
07:08

Eli Lilly to acquire veterinary vaccine portfolio from Boehringer Ingelheim

Eli Lilly subsidiary Elanco U.S. announced an agreement with Boehringer Ingelheim Vetmedica to acquire a portfolio of U.S. canine, feline and rabies vaccines, as well as a fully integrated manufacturing and R&D site. The sale price of $885M includes the estimated cost of acquired inventory. The deal is conditioned on antitrust approval and closing of the Boehringer Ingelheim asset swap transaction with Sanofi that was signed in June. The current BIVI vaccine portfolio has experienced consistent revenue growth over the past three years. The sale to Elanco is anticipated to close by early 2017 subject to approval by the Federal Trade Commission, and other contingencies.

  • 07

    Oct

  • 25

    Oct

  • 06

    Nov

LLY Eli Lilly
$81.11

0.11 (0.14%)

09/28/16
BERN
09/28/16
NO CHANGE
BERN
Biogen likely to benefit from Lilly Alzheimer's drug results, says Bernstein
Bernstein analyst Aaron Gal says that the results of a trial of Eli Lilly's (LLY) Alzheimer's drug, solanezumab, due out in late 2016 or early 2017, are likely to impact perceptions of Biogen's (BIIB) Alzheimer's drug, aducanumab. The analyst expects Lilly's solanezumab "to show at least directional evidence" of cognitive improvement, although he is "less convinced" that the impact will be clearly statistically significant. The best results from Biogen's perspective will be if Lilly's drug shows "marginal success," according to Gal. However, statistically significant results are also good for Biogen, as they will show that reducing amyloid beta does mitigate Alzheimer's symptoms, the analyst stated. And if Lilly's drug completely fails, Biogen's drug "could well succeed," given the significant differences between them, wrote Gal,who gives Biogen's aducanumab a 65% chance of success. He keeps a $345 price target and Outperform rating on Biogen.
09/27/16
09/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Buy from Neutral at Goldman with analyst Jami Rubin saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. 2. AutoZone (AZO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying the company is at a positive inflection in 7 year and older vehicles, which is strongly correlated to same-store-sales. 3. Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI with analyst Greg Gordon saying the joint settlement proposal filed in the CECONY rate case mitigates downside risk. 4. Crown Holdings (CCK) upgraded on multiple catalysts at BMO Capital with analyst Mark Wilde citing valuation, his belief that the company will resume returning cash to shareholders in 2017, and his belief that the company's results should be boosted by " a wave of domestic and offshore expansion projects." 5. Francesca's (FRAN) upgraded to Buy from Hold at Stifel with analyst Richard Jaffe saying the company's "appealing merchandise" makes it very likely that its sales will grow going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
GSCO
09/27/16
UPGRADE
Target $95
GSCO
Buy
Eli Lilly upgraded to Buy from Neutral at Goldman
Goldman analyst Jami Rubin upgraded Eli Lilly to Buy and increased its price target to $95 from $89 saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. Rubin projects $12.5B of new product sales by 2020 and double digit earnings growth over the next five years, even without Sola. The analyst sees a 35%, up from 25%, probability of success for Sola with a bull case scenario that can lead to almost $7.5B in peak sales and "super charge" earnings. Even without Sola, Rubin sees favorable risk/reward given durability of earnings and said it is the least exposed to above-CPI price increases.
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).

TODAY'S FREE FLY STORIES

02:50
12/07/16
12/07
02:50
12/07/16
02:50
General news
FX Update: The dollar has traded steady-to-firmer »

FX Update: The dollar…

VRA

Vera Bradley

$14.67

-0.07 (-0.47%)

20:25
12/06/16
12/06
20:25
12/06/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WPPGY

WPP PLC

$105.77

-1.18 (-1.10%)

, FB

Facebook

$117.31

-0.12 (-0.10%)

20:11
12/06/16
12/06
20:11
12/06/16
20:11
Periodicals
WPP CEO says spending about $70M with Snapchat, WSJ says »

Speaking earlier Tuesday…

WPPGY

WPP PLC

$105.77

-1.18 (-1.10%)

FB

Facebook

$117.31

-0.12 (-0.10%)

GOOG

Alphabet

$759.11

-3.41 (-0.45%)

GOOGL

Alphabet Class A

$776.18

-2.04 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 15

    Jan

GLT

Glatfelter

$24.29

0.67 (2.84%)

20:09
12/06/16
12/06
20:09
12/06/16
20:09
Downgrade
Glatfelter rating change  »

Glatfelter downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPRX

Repros Therapeutics

$1.91

-0.04 (-2.05%)

20:06
12/06/16
12/06
20:06
12/06/16
20:06
Hot Stocks
Repros participates in FDA meeting, says plans meeting to discuss Phase 3 design »

Repros Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$185.85

-0.95 (-0.51%)

, SSNLF

Samsung

19:57
12/06/16
12/06
19:57
12/06/16
19:57
Hot Stocks
Electric car startup partners with Samsung SDI on 'breakthrough' battery tech »

Electric vehicle startup…

TSLA

Tesla

$185.85

-0.95 (-0.51%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 08

    Dec

  • 14

    Dec

  • 10

    Jan

SBMRY

SABMiller

, BUD

AB InBev

$104.05

0.79 (0.77%)

19:34
12/06/16
12/06
19:34
12/06/16
19:34
Periodicals
Bain Capital exits auction for European SABMiller brands, Reuters says »

Private equity firm Bain…

SBMRY

SABMiller

BUD

AB InBev

$104.05

0.79 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$46.86

1.28 (2.81%)

19:27
12/06/16
12/06
19:27
12/06/16
19:27
Hot Stocks
Senators: AutoNation resumption of recalled vehicle sales 'deeply troubling' »

U.S. Senators Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$152.24

0.08 (0.05%)

19:21
12/06/16
12/06
19:21
12/06/16
19:21
Periodicals
Boeing contacts Trump team after Air Force One tweets, Bloomberg says »

Following President-elect…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$152.24

0.08 (0.05%)

18:58
12/06/16
12/06
18:58
12/06/16
18:58
Hot Stocks
White House press secretary: Air Force One claims appear misrepresentative »

Responding to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$52.37

0.17 (0.33%)

, RDS.B

Royal Dutch Shell

$55.72

0.21 (0.38%)

18:51
12/06/16
12/06
18:51
12/06/16
18:51
Periodicals
Japan-based Idemitsu plans purchase of Showa Shell stake, Nikkei says »

Japan's Idemitsu…

RDS.A

Royal Dutch Shell

$52.37

0.17 (0.33%)

RDS.B

Royal Dutch Shell

$55.72

0.21 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$117.88

0.32 (0.27%)

18:48
12/06/16
12/06
18:48
12/06/16
18:48
Periodicals
Toyota plans to improve overall fuel economy by 20%, Nikkei reports »

Toyota plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYA

Amaya

$14.60

0.2 (1.39%)

18:35
12/06/16
12/06
18:35
12/06/16
18:35
Periodicals
Amaya holder SpringOwl: Baazov bid 'raises a lot of questions,' Bloomberg says »

Speaking in a Bloomberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$185.85

-0.95 (-0.51%)

18:30
12/06/16
12/06
18:30
12/06/16
18:30
Hot Stocks
Tesla to recall certain NEMA 14-30, 10-30, 6-50 charging adapters »

Tesla said that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 10

    Jan

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:21
12/06/16
12/06
18:21
12/06/16
18:21
Hot Stocks
Allegiant Travel says estimated November TRASM change (2.7%)-(2.3%) »

November estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:14
12/06/16
12/06
18:14
12/06/16
18:14
Hot Stocks
Allegiant Travel sees Q1 system departures up 14%-18%, ASMs up 10%-14% »

Sees Q1 scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

Tsakos Energy

$4.82

0.16 (3.43%)

18:13
12/06/16
12/06
18:13
12/06/16
18:13
Hot Stocks
Tsakos Energy announces four new time charter contracts »

Tsakos Energy Navigation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:12
12/06/16
12/06
18:12
12/06/16
18:12
Hot Stocks
Allegiant Travel sees Q4 system departures up 17%-19%, ASMs up 12%-14% »

Sees Q4 scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:11
12/06/16
12/06
18:11
12/06/16
18:11
Hot Stocks
Breaking Hot Stocks news story on Allegiant Travel »

Allegiant Travel sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:09
12/06/16
12/06
18:09
12/06/16
18:09
Hot Stocks
Allegiant Travel revises Q4 TRASM view to (6%)-(4.5%) from (7.5%)-(5.5%) »

"November close in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGT

Allegiant Travel

$162.35

4.1 (2.59%)

18:07
12/06/16
12/06
18:07
12/06/16
18:07
Hot Stocks
Allegiant Travel reports preliminary November traffic up 8.7% »

Reports November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMAB

OMA Airports

$36.17

0.23 (0.64%)

18:01
12/06/16
12/06
18:01
12/06/16
18:01
Hot Stocks
OMA Airports reports November passenger traffic up 11.3% »

OMA Airports reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

III

Information Services

$3.90

0.04 (1.04%)

18:00
12/06/16
12/06
18:00
12/06/16
18:00
Hot Stocks
Chevrillon raises passive stake in Information Services to 13.55% from 7.2% »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

SAGE Therapeutics

$55.68

3.86 (7.45%)

17:59
12/06/16
12/06
17:59
12/06/16
17:59
Recommendations
SAGE Therapeutics analyst commentary  »

BMO ups SAGE target to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AKS

AK Steel

$10.55

-0.1 (-0.94%)

17:47
12/06/16
12/06
17:47
12/06/16
17:47
Hot Stocks
AK Steel to increase base prices for all stainless products »

AK Steel said that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.